Search Results
Found 1 results
510(k) Data Aggregation
(49 days)
AIA-PACK TSH 3RD-GEN ASSAY
AIA-PACK TSH 3rd-Gen is intended for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of thyroid stimulating hormone (thyrotrophin) in human serum on TOSOH AIA System analyzers. Measurements obtained by human serum on TOSOH AIA Syste numan serum on 100017 M : System any of thyroid or pituitary disorders.
Not Found
It appears you've provided snippets from an FDA 510(k) clearance letter for the "AIA-PACK TSH 3rd-Gen Assay". This document is an FDA clearance letter, which confirms the device is substantially equivalent to a predicate device and can be marketed. It does not contain the detailed study information, acceptance criteria, or performance data that you've requested.
The FDA clearance letter primarily focuses on:
- Confirming the device's classification (Class II).
- Stating that it's substantially equivalent to a predicate device.
- Listing general controls and regulatory requirements.
- Providing contact information for various FDA offices.
To answer your specific questions (acceptance criteria, study details, sample sizes, ground truth, expert qualifications, etc.), you would typically need to refer to:
- The 510(k) summary document submitted by the manufacturer to the FDA, which often includes a summary of performance data.
- The full 510(k) submission, if publicly available or requested from the manufacturer, which would contain the detailed study protocols and results.
- Peer-reviewed publications related to the device.
Therefore, based only on the provided text, I cannot answer most of your detailed questions about the study design and acceptance criteria.
However, I can extract the following limited information:
- Device Name: AIA-PACK TSH 3rd-Gen Assay
- Intended Use: For IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of thyroid stimulating hormone (thyrotrophin) in human serum on TOSOH AIA System analyzers. Measurements obtained by human serum on TOSOH AIA Syste numan serum on 100017 M : System any of thyroid or pituitary disorders. (There appears to be a transcription error in the last part of this sentence in the provided document).
- Regulatory Class: II
- Product Code: JLW, JIS
To illustrate what you're asking for, if this were a document that did contain the information, here's how a hypothetical answer might appear, with placeholders for the actual data that is missing from your provided text:
Based on the typical structure of device clearance documentation, the following information would be found in the 510(k) summary or full submission. The provided FDA clearance letter does not contain these details directly.
1. Table of Acceptance Criteria and Reported Device Performance
Performance Metric | Acceptance Criteria (Hypothetical) | Reported Device Performance (Hypothetical) |
---|---|---|
Analytical Sensitivity (Limit of Detection) | ≤ 0.01 mIU/L | 0.005 mIU/L |
Functional Sensitivity | ≤ 0.02 mIU/L | 0.015 mIU/L |
Intra-assay Precision (CV%) | 0.98, Slope 0.95-1.05, Intercept near 0 | R = 0.992, Slope = 1.01, Intercept = 0.002 |
Interference (Hemolysis, Lipemia, Bilirubin) |
Ask a specific question about this device
Page 1 of 1